UTHR vs. HBM
UTHR (United Therapeutics Corporation) and HBM (Hudbay Minerals Inc.) are both stocks. UTHR operates in Biotechnology (Healthcare), while HBM operates in Copper (Basic Materials). Over the past 10 years, UTHR returned 17.20%/yr vs 18.60%/yr for HBM. At a 0.20 correlation, their price movements are largely independent.
Performance
UTHR vs. HBM - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, UTHR achieves a 11.79% return, which is significantly lower than HBM's 31.58% return. Over the past 10 years, UTHR has underperformed HBM with an annualized return of 17.20%, while HBM has yielded a comparatively higher 18.60% annualized return.
UTHR
- 1D
- -0.94%
- 1M
- -3.58%
- YTD
- 11.79%
- 6M
- 13.59%
- 1Y
- 67.18%
- 3Y*
- 33.59%
- 5Y*
- 25.53%
- 10Y*
- 17.20%
HBM
- 1D
- 1.75%
- 1M
- 4.36%
- YTD
- 31.58%
- 6M
- 50.45%
- 1Y
- 171.66%
- 3Y*
- 77.46%
- 5Y*
- 30.42%
- 10Y*
- 18.60%
UTHR vs. HBM - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
UTHR United Therapeutics Corporation | 11.79% | 38.09% | 60.46% | -20.93% | 28.70% | 42.35% | 72.33% | -19.12% | -26.39% | 3.15% |
HBM Hudbay Minerals Inc. | 31.58% | 145.46% | 47.03% | 9.24% | -29.87% | 3.82% | 69.50% | -11.77% | -46.20% | 54.77% |
Correlation
The correlation between UTHR and HBM is 0.11, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.11 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.10 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.12 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.18 |
Correlation (All Time) Calculated using the full available price history since Feb 13, 2009 | 0.20 |
Fundamentals
UTHR:
$25.71B
HBM:
$10.41B
UTHR:
$27.00
HBM:
$1.65
UTHR:
20.17
HBM:
15.79
UTHR:
0.66
HBM:
0.11
UTHR:
8.19
HBM:
4.39
UTHR:
4.36
HBM:
2.94
UTHR:
$3.17B
HBM:
$2.37B
UTHR:
$2.74B
HBM:
$828.54M
UTHR:
$1.75B
HBM:
$1.54B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
UTHR vs. HBM — Risk / Return Rank
UTHR
HBM
UTHR vs. HBM - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for United Therapeutics Corporation (UTHR) and Hudbay Minerals Inc. (HBM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| UTHR | HBM | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.60 | ||
| Sortino ratioReturn per unit of downside risk | -0.33 | ||
| Omega ratioGain probability vs. loss probability | 1.37 | 1.41 | -0.04 |
| Calmar ratioReturn relative to maximum drawdown | 4.13 | 4.78 | -0.65 |
| Martin ratioReturn relative to average drawdown | 10.54 | 15.13 | -4.59 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| UTHR | HBM | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.36 | 2.96 | -1.60 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.73 | 0.55 | +0.18 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.49 | 0.32 | +0.17 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.38 | 0.20 | +0.18 |
Drawdowns
UTHR vs. HBM - Drawdown Comparison
The maximum UTHR drawdown since its inception was -93.18%, roughly equal to the maximum HBM drawdown of -92.21%. Use the drawdown chart below to compare losses from any high point for UTHR and HBM.
Loading charts...
Drawdown Indicators
| UTHR | HBM | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -93.18% | -92.21% | -0.97% |
Max Drawdown (1Y)Largest decline over 1 year | -16.35% | -36.16% | +19.81% |
Max Drawdown (3Y)Largest decline over 3 years | -33.00% | -41.11% | +8.11% |
Max Drawdown (5Y)Largest decline over 5 years | -33.00% | -63.33% | +30.33% |
Max Drawdown (10Y)Largest decline over 10 years | -55.56% | -86.34% | +30.78% |
Current DrawdownCurrent decline from peak | -8.73% | -18.07% | +9.34% |
Average DrawdownAverage peak-to-trough decline | -35.31% | -52.50% | +17.19% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 6.39% | 11.40% | -5.01% |
Volatility
UTHR vs. HBM - Volatility Comparison
The current volatility for United Therapeutics Corporation (UTHR) is 5.15%, while Hudbay Minerals Inc. (HBM) has a volatility of 25.29%. This indicates that UTHR experiences smaller price fluctuations and is considered to be less risky than HBM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| UTHR | HBM | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.15% | 25.29% | -20.14% |
Volatility (6M)Calculated over the trailing 6-month period | 26.01% | 46.90% | -20.89% |
Volatility (1Y)Calculated over the trailing 1-year period | 49.84% | 58.55% | -8.71% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 35.13% | 55.36% | -20.23% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 35.07% | 58.79% | -23.72% |
Dividends
UTHR vs. HBM - Dividend Comparison
UTHR has not paid dividends to shareholders, while HBM's dividend yield for the trailing twelve months is around 0.05%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
HBM Hudbay Minerals Inc. | 0.05% | 0.07% | 0.17% | 0.31% | 0.32% | 0.22% | 0.21% | 0.36% | 0.38% | 0.23% | 0.35% | 0.52% |
UTHR United Therapeutics Corporation | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
UTHR vs. HBM - Financials Comparison
This section allows you to compare key financial metrics between United Therapeutics Corporation and Hudbay Minerals Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
UTHR vs. HBM - Profitability Comparison
UTHR - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, United Therapeutics Corporation reported a gross profit of 648.10M and revenue of 781.50M. Therefore, the gross margin over that period was 82.9%.
HBM - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Hudbay Minerals Inc. reported a gross profit of 340.81M and revenue of 745.43M. Therefore, the gross margin over that period was 45.7%.
UTHR - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, United Therapeutics Corporation reported an operating income of 325.80M and revenue of 781.50M, resulting in an operating margin of 41.7%.
HBM - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Hudbay Minerals Inc. reported an operating income of 297.62M and revenue of 745.43M, resulting in an operating margin of 39.9%.
UTHR - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, United Therapeutics Corporation reported a net income of 274.90M and revenue of 781.50M, resulting in a net margin of 35.2%.
HBM - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Hudbay Minerals Inc. reported a net income of 187.76M and revenue of 745.43M, resulting in a net margin of 25.2%.
Frequently Asked Questions
UTHR and HBM have a correlation of 0.11, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
HBM has higher volatility (25.29%) compared to UTHR (5.15%). In terms of maximum drawdown, UTHR dropped -93.18% vs HBM's -92.21%.
HBM currently has the higher Sharpe Ratio (2.96 vs 1.36), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for UTHR and HBM
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer